-
hcup-us.ahrq.gov/reports/statbriefs/sb104.pdf
January 04, 2011 - HCUP data include OB-GYN, ENT,
orthopedic, cancer, pediatric, public, and academic medical hospitals
-
digital.ahrq.gov/sites/default/files/Stakeholder%20Center%20Quarterly%20Report%20One_Jan26.pdf
June 01, 2022 - Leadership
CDS Outcomes and
Objectives
Chair: Gilad Kuperman, MD, PhD (Memorial Sloan Kettering Cancer
-
digital.ahrq.gov/sites/default/files/docs/publication/r18hs018275-parsons-final-report-2013.pdf
January 01, 2013 - patients and lower prevalence of chronic conditions such as diabetes, hypertension, high
cholesterol, or cancer
-
hcup-us.ahrq.gov/reports/natstats/his95/appb.htm
January 01, 2001 - 9904 9905 9906 9907 9908 9909
223 Enteral and parenteral nutrition
966 9915
224 Cancer
-
hcup-us.ahrq.gov/reports/statbriefs/sb122.pdf
October 01, 2011 - HCUP includes data from OB-GYN,
ENT, orthopedic, cancer, pediatric, public, and academic medical hospitals
-
hcup-us.ahrq.gov/reports/statbriefs/sb124.pdf
January 01, 2012 - HCUP data include OB-GYN, ENT,
orthopedic, cancer, pediatric, public, and academic medical hospitals
-
hcup-us.ahrq.gov/reports/statbriefs/sb75.pdf
June 01, 2009 - HCUP data include OB-GYN, ENT,
orthopedic, cancer, pediatric, public, and academic medical hospitals
-
hcup-us.ahrq.gov/reports/statbriefs/sb135.pdf
March 01, 2012 - HCUP data include obstetrics and
gynecology, otolaryngology, orthopedic, cancer, pediatric, public,
-
hcup-us.ahrq.gov/reports/statbriefs/sb96.pdf
September 01, 2010 - HCUP data include OB-GYN, ENT,
orthopedic, cancer, pediatric, public, and academic medical hospitals
-
hcup-us.ahrq.gov/reports/statbriefs/sb73.pdf
May 01, 2009 - HCUP data include OB-GYN, ENT,
orthopedic, cancer, pediatric, public, and academic medical hospitals
-
hcup-us.ahrq.gov/reports/statbriefs/sb103.pdf
December 01, 2010 - HCUP data include OB-GYN, ENT,
orthopedic, cancer, pediatric, public, and academic medical hospitals
-
hcup-us.ahrq.gov/reports/statbriefs/sb80.pdf
October 01, 2009 - HCUP data include OB-GYN, ENT,
orthopedic, cancer, pediatric, public, and academic medical hospitals
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/2_e9yUNkzrtkkNKmn7YtCU
September 01, 2012 - Because the
WHI was primarily designed to detect differences in breast
cancer rather than CVD, its power
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/nnkwqkX-Nk6v3gsphVATUD
September 01, 2002 - Harms
of hormone replacement therapy include venous
thromboembolic events, endometrial cancer, and
cholecystitis
-
digital.ahrq.gov/sites/default/files/docs/citation/r21hs026322-dorsch-final-report-2021.pdf
January 01, 2021 - four standard survey questions have been used in previous research to assess
understanding of risk in cancer
-
www.ahrq.gov/sites/default/files/2025-06/haut-report.pdf
January 01, 2025 - effective prophylaxis, more than 100,000 patients die from PE each
year – more than from AIDS, breast cancer
-
www.ahrq.gov/sites/default/files/2025-03/lacson2-report.pdf
January 01, 2025 - Recurrent CT, cumulative radiation exposure, and associated radiation-induced cancer
risks from CT of
-
effectivehealthcare.ahrq.gov/health-topics/anemia
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/jmCXJwxefa67VY4NfD8gUg
June 26, 2018 - 0.88 [95%
CI, 0.56-1.40]),117 stroke (0.9% vs 1.2%; RR, 0.69 [95% CI,
0.40-1.18]),118 or endometrial cancer … gestin, compared with women receiving placebo, were found to have
a higher risk of invasive breast cancer … Cancers were reported in 2 groups (3/147 in the placebo group
and 3/151 in the 20-μg treatment group) … Continued breast cancer risk reduction in
postmenopausal women treated with raloxifene:
4-year results … Breast Cancer
Res Treat. 2001;65(2):125-134. doi:10.1023/A:
1006478317173
120.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain-2006_appendixes.pdf
January 01, 2006 - the area of the lumbar
spine; severe cardias, hepatic,
renal, hematological or metabolic
disease, cancer … Funding
Bensen/Zhao no fair NR/NR/1003 Concomitant GI, renal hepatic or coagulation disorder;
malignancy … use within 48 hrs
of baseline assessment; concomitant GI, renal, hepatic or
coagulation disorder; malignancy … estimated creatinine
clearance of 30 ml or less/minute;
an unstable medical condition;
hisotyr of cancer … Merck
Research
Labs
Chrubasik NR fair NR/NR/228 Any recent trauma; age >50 or <20;
history of cancer